ArticleMolecular oncology2018

Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.

Margaret Stromecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.